Why the study?
Advances in anticoagulation and ablation have occurred since previous healthcare resource utilization analyses of patients with atrial fibrillation.
Despite advances in anticoagulation and ablation, healthcare resource utilization remains high for patients with newly diagnosed atrial fibrillation in the US.
High resource use in incident AF may support targeted allocation; leaves open optimal strategies pending prospective validation.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Zeitler et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: